Bibliography for TMSPHASPSM01: MSc Pharmacogenetics and Stratified Medicine BETA

Abou-Sleiman, P.M., Muqit, M.M.K. and Wood, N.W. (2006) ‘Expanding insights of mitochondrial dysfunction in Parkinson’s disease’, Nature Reviews Neuroscience, 7(3), pp. 207–219. Available at: https://doi.org/10.1038/nrn1868.

Altshuler, D., Daly, M.J. and Lander, E.S. (2008) ‘Genetic Mapping in Human Disease’, Science, 322(5903), pp. 881–888. Available at: https://doi.org/10.1126/science.1156409.

Antonarakis, S.E. and Beckmann, J.S. (2006) ‘Mendelian disorders deserve more attention’, Nature Reviews Genetics, 7(4), pp. 277–282. Available at: https://doi.org/10.1038/nrg1826.

Atherosclerosis — An Inflammatory Disease — NEJM (no date).

Balding, D.J. (2006) ‘A tutorial on statistical methods for population association studies’, Nature Reviews Genetics, 7(10), pp. 781–791. Available at: https://doi.org/10.1038/nrg1916.

Bishop, M., Cannings, C., and Balding, D. J. (2007) Handbook of statistical genetics. 3rd ed. Chichester: John Wiley. Available at: https://onlinelibrary.wiley.com/doi/book/10.1002/9781119487845.

Botstein, D. and Risch, N. (2003) ‘Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease’, Nature Genetics, 33(3s), pp. 228–237. Available at: https://doi.org/10.1038/ng1090.

Bras, J.M. and Singleton, A. (2009) ‘Genetic susceptibility in Parkinson’s disease’, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1792(7), pp. 597–603. Available at: https://doi.org/10.1016/j.bbadis.2008.11.008.

Brinkman, R.R. et al. (2006) ‘Human monogenic disorders — a source of novel drug targets’, Nature Reviews Genetics, 7(4), pp. 249–260. Available at: https://doi.org/10.1038/nrg1828.

Burton, Paul, Palmer, Lyle, and Smith, George Davey (2011) An introduction to genetic epidemiology. Bristol: Policy Press.

Capecchi, M.R. (2005) ‘Essay: Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century’, Nature Reviews Genetics, 6(6), pp. 507–512. Available at: https://doi.org/10.1038/nrg1619.

Daly, A.K. (2010) ‘Genome-wide association studies in pharmacogenomics’, Nature Reviews Genetics, 11(4), pp. 241–246. Available at: https://doi.org/10.1038/nrg2751.

Foulkes, Andrea S. (2009) Applied statistical genetics with R: for population-based association studies. Dordrecht: Springer. Available at: https://doi.org/10.1007/978-0-387-89554-3.

Gibb, Alasdair J., Foreman, John C., and Johansen, Torben (2011) Textbook of receptor pharmacology. 3rd ed. Boca Raton, FL: CRC Press. Available at: https://doi.org/10.1201/9781420052558.

Hall, I.P. and Pirmohamed, M. (2006) Pharmacogenetics. New York: Taylor & Francis. Available at: https://doi.org/10.3109/9781420016697.

Hansson, G.K. and Libby, P. (2006) ‘The immune response in atherosclerosis: a double-edged sword’, Nature Reviews Immunology, 6(7), pp. 508–519. Available at: https://doi.org/10.1038/nri1882.

Hirschhorn, J.N. and Daly, M.J. (2005) ‘Genome-wide association studies for common diseases and complex traits’, Nature Reviews Genetics, 6(2), pp. 95–108. Available at: https://doi.org/10.1038/nrg1521.

Holmes, M.V. et al. (2009a) ‘Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies’, PLoS ONE, 4(12). Available at: https://doi.org/10.1371/journal.pone.0007960.

Holmes, M.V. et al. (2009b) ‘Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies’, PLoS ONE, 4(12). Available at: https://doi.org/10.1371/journal.pone.0007960.

Holmes, M.V. (2011) ‘CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular EventsA Systematic Review and Meta-analysis’, JAMA: The Journal of the American Medical Association, 306(24). Available at: https://doi.org/10.1001/jama.2011.1880.

Humphries, S.E. and Hingorani, A. (2006) ‘Pharmacogenetics: Progress, pitfalls and clinical potential for coronary heart disease’, Vascular Pharmacology, 44(2), pp. 119–125. Available at: https://doi.org/10.1016/j.vph.2005.10.003.

Kathiresan, S. et al. (2009) ‘Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants’, Nature Genetics, 41(3), pp. 334–341. Available at: https://doi.org/10.1038/ng.327.

Kenakin, Terrence P. (2009) A pharmacology primer: theory, applications, and methods. 3rd ed. Burlington, MA: Elsevier Academic Press. Available at: https://www-sciencedirect-com.libproxy.ucl.ac.uk/book/9780123745859/a-pharmacology-primer.

Kirkwood, Betty R., Kirkwood, Betty R., and Sterne, Jonathan A. C. (2003) Essential medical statistics. 2nd ed. Malden, Mass: Blackwell Science.

Lee, A.J.X. and Swanton, C. (2012) ‘Tumour heterogeneity and drug resistance: Personalising cancer medicine through functional genomics’, Biochemical Pharmacology, 83(8), pp. 1013–1020. Available at: https://doi.org/10.1016/j.bcp.2011.12.008.

Lefkowitz, R.J. (2004) ‘Historical review: A brief history and personal retrospective of seven-transmembrane receptors’, Trends in Pharmacological Sciences, 25(8), pp. 413–422. Available at: https://doi.org/10.1016/j.tips.2004.06.006.

Lesk, Arthur M. (2008) Introduction to bioinformatics. 3rd ed. Oxford: Oxford University Press.

McCarthy, M.I. et al. (2008) ‘Genome-wide association studies for complex traits: consensus, uncertainty and challenges’, Nature Reviews Genetics, 9(5), pp. 356–369. Available at: https://doi.org/10.1038/nrg2344.

Neale, Benjamin M. and International Workshop of Twin and Family Studies (2008) Statistical genetics: gene mapping through linkage and association. Abingdon: Taylor & Francis.

Neubig, R.R. (2003) ‘International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology’, Pharmacological Reviews, 55(4), pp. 597–606. Available at: https://doi.org/10.1124/pr.55.4.4.

‘New Perspectives for the Elucidation of Genetic Disorders’ (no date). Available at: https://doi.org/520679.

O’Connor, T.P. and Crystal, R.G. (2006) ‘Genetic medicines: treatment strategies for hereditary disorders’, Nature Reviews Genetics, 7(4), pp. 261–276. Available at: https://doi.org/10.1038/nrg1829.

Orengo, Christine Ann, Jones, David Tudor, and Thornton, Janet M. (2003) Bioinformatics: genes, proteins and computers. Oxford: BIOS. Available at: https://www.vlebooks.com/Product/Index/2052147?page=0&startBookmarkId=-1.

Ropers, H.-H. (2007) ‘New Perspectives for the Elucidation of Genetic Disorders’, The American Journal of Human Genetics, 81(2), pp. 199–207. Available at: https://doi.org/10.1086/520679.

Seifert, R. and Wenzel-Seifert, K. (2002) ‘Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors’, Naunyn-Schmiedeberg’s Archives of Pharmacology, 366(5), pp. 381–416. Available at: https://doi.org/10.1007/s00210-002-0588-0.

Sham, P. (2007) Statistics in human genetics. Chichester: Wiley.

Table of contents : Nature Reviews Genetics Focus on Monogenic disorders (no date).

Thomas, Duncan C. (2004) Statistical methods in genetic epidemiology. New York: Oxford University Press.

Thompson, A.J., Lester, H.A. and Lummis, S.C.R. (2010) ‘The structural basis of function in Cys-loop receptors’, Quarterly Reviews of Biophysics, 43(04), pp. 449–499. Available at: https://doi.org/10.1017/S0033583510000168.

Yusuf, S. et al. (2004) ‘Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study’, The Lancet, 364(9438), pp. 937–952. Available at: https://doi.org/10.1016/S0140-6736(04)17018-9.

Zvelebil, Marketa J. and Baum, Jeremy O. (2008) Understanding bioinformatics. New York: Garland Science. Available at: https://bibliu.com/app/#/view/books/9781136976964/pdf2htmlex/index.html#page_Cover.